Drug Inspector's findings at an ESIC campus pharmacy
During a routine inspection of a retail pharmacy on an ESIC hospital campus, a Drugs Inspector appointed under Section 21 of the Drugs and Cosmetics Act records the following on 12 June 2024: (i) the Schedule H1 register has no entries after 30 April 2024, although invoices show 46 vials of ceftriaxone injection 1 g were sold in May; (ii) a prescription dated 3 June 2024 for alprazolam 0.5 mg tablets, one at night for 10 days, bears the prescriber's name and registration number but is endorsed 'repeat twice'; (iii) two bottles of amoxicillin 250 mg/5 mL dry syrup with expiry 02/2024 are standing on the dispensing shelf; (iv) the pharmacist on duty states that he is a D.Pharm registered with the State Pharmacy Council and that the ceftriaxone was 'sold only to doctors, so no prescription or register entry was needed'.
1. Analyse each finding: which statutory requirement is breached and what are the likely consequences for the licensee and the pharmacist?
Read the worked answer
Finding (i) - Schedule H1 register. Drugs listed in Schedule H1 (which include third-generation cephalosporins such as ceftriaxone, certain carbapenems, anti-tuberculosis drugs and specified habit-forming drugs) may be sold only against the prescription of a registered medical practitioner, and the retailer must maintain a separate register for three years recording the name and address of the prescriber, the name of the patient, the name and quantity of the drug, and the date. The label must additionally carry the symbol 'Rx' in red and a boxed warning. Forty-six vials with no entries is a clear contravention of the conditions of the retail licence under the Drugs and Cosmetics Rules, exposing the licensee to suspension or cancellation of the licence by the Licensing Authority and to prosecution.
Finding (ii) - 'Repeat twice' on alprazolam. Schedule H permits a limited number of refills where the prescriber so directs. Schedule H1 does not: a fresh prescription is required each time. Depending on the current listing, alprazolam is a controlled benzodiazepine and a repeat endorsement is not a lawful authority to dispense twice more. Dispensing on it would itself be a sale without a valid prescription.
Finding (iii) - expired amoxicillin. Expired stock on a dispensing shelf is a sale of a drug not of standard quality, an offence under the Act, and it also indicates a failed expiry-date monitoring system. The stock and its invoices should be seized; prosecution follows under the relevant penalty provision (broadly, imprisonment of three months to three years with fine), and the licence is at risk.
Finding (iv) - 'sold to doctors'. A sale is a sale. A retail licence authorises supply to the consumer against prescription; supplying in bulk to doctors requires a wholesale licence for that purpose, and the H1 documentation requirement is not waived by the buyer's profession. Registration with the State Pharmacy Council under the Pharmacy Act governs who may dispense; it does not excuse compliance with the Drugs and Cosmetics Act.
2. The Inspector decides to draw a sample of the expired amoxicillin syrup. Describe the correct sampling procedure and what happens if the analyst's report is disputed.
Read the worked answer
Sampling under the Act. The Inspector exercises powers under the Act to take samples of any drug from any person in possession of it for sale or distribution, on payment of the market price, and must divide the sample into four portions, each marked and sealed in the manner prescribed. The Inspector offers one portion to the person from whom the sample is taken, sends one to the Government Analyst for testing, retains one for production before the court if proceedings are instituted, and keeps the fourth in safe custody. A receipt in the prescribed form (Form 17) is given for the sample, and the Inspector informs the person of the intention to test it.
Report. The Government Analyst issues a report in the prescribed form, stating the result of the test. If the sample is reported not of standard quality, the Inspector may launch prosecution.
Dispute. The person from whom the sample was taken may, within 28 days of receiving the report, notify the Inspector of the intention to adduce evidence in controversion of the report, and may apply to the court for an order to send the retained portion to the Central Drugs Laboratory, on payment of the prescribed fee. The CDL's report is conclusive evidence of the facts stated. Practical points for the pharmacist: never break the seal, store the retained portion as directed, and keep every invoice and stock record, because the documentary trail is what actually decides these cases.
3. The licensee argues that the register lapse was clerical and that he should be let off with an advisory letter. How would you assess that argument, and what compliance system should the pharmacy put in place?
Read the worked answer
Assessing the argument. A one-off omission and a two-month systemic gap are different things. Here there is a documented volume of 46 vials with no entries, plus a repeat endorsement on a controlled benzodiazepine, plus expired stock on an active shelf - three independent failures. That pattern indicates a broken system, not a clerical slip, so an advisory letter alone does not fit the facts; the Inspector's discretion is exercised against the seriousness of the contravention, and prosecution and licence action remain open.
Aggravating and mitigating factors. Aggravating: a hospital campus pharmacy serving patients should be a model of compliance; the explanation 'sold to doctors' shows a misunderstanding of the law. Mitigating: no allegation of spurious drugs, cooperation with the inspection, and no previous adverse record - these may be put before the Licensing Authority, but they do not convert an offence into no offence.
Compliance system to install:
- A single log at the point of sale for every Schedule H1 item: prescriber name and registration number, patient name and address, drug, quantity and date, entered at the moment of dispensing, with the prescription retained for the statutory period.
- Colour-coded shelving and labels for Schedule H, H1 and X, with H1 labels carrying the red 'Rx' symbol and the boxed warning.
- No refill without a fresh prescription for H1, and a written rule that no repeat endorsement authorises an H1 refill.
- A monthly expiry sweep with a date log and a quarantine bin for near-expiry stock, signed off by a named person.
- A short SOP binder covering sampling, storage of recalled stock, and what to do when an Inspector arrives; all staff trained and the training recorded.
The pharmacy's own registration records and the licences on display should be checked at the same visit, since an Inspector will look at those next.